Article
Treatment Guidelines and Early Loss from Care for People Living with HIV in Cape Town, South Africa: A Retrospective Cohort Study
PLoS Medicine
Sponsor
U.S. National Institute for Mental Health K23 MH097667.
Document Type
Article
Publication Date
11-14-2017
Subjects
- Antiretroviral treatment -- Initiation,
- Patient refusal of treatment,
- HIV infections -- South Africa -- Treatment
Disciplines
Abstract
South Africa has undergone multiple expansions in antiretroviral therapy (ART) eligibility from an initial CD4+ threshold of ≤200 cells/μl to providing ART for all people living with HIV (PLWH) as of September 2016. We evaluated the association of programmatic changes in ART eligibility with loss from care, both prior to ART initiation and within the first 16 weeks of starting treatment, during a period of programmatic expansion to ART treatment at CD4+ ≤ 350 cells/μl.
DOI
10.1371/journal.pmed.1002434
Persistent Identifier
http://archives.pdx.edu/ds/psu/22656
Citation Information
Katz, I. T., Kaplan, R., Fitzmaurice, G., Leone, D., Bangsberg, D. R., Bekker, L. G., & Orrell, C. (2017). Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study. PLoS medicine, 14(11), e1002434.
Copyright: © 2017 Katz et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.